FindTrial
Sign In

7-valent pneumococcal conjugate vaccine

BIOLOGICAL12 trials

Sponsors

Centers for Disease Control and Prevention, The Hospital for Sick Children, Wyeth is now a wholly owned subsidiary of Pfizer, National and Kapodistrian University of Athens, Pfizer

Conditions

Diseases Caused by Streptococcus Pneumoniae SerotypesIdiopathic Nephrotic SyndromeImmunosuppressionOrgan TransplantPneumococcal InfectionPneumococcal InfectionsPneumococcal VaccineVaccines, Pneumococcal

Phase 1

Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine
CompletedNCT00164411
Centers for Disease Control and PreventionPneumococcal Infections
Start: 2004-01-31End: 2005-03-31Target: 30Updated: 2012-03-14
Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants
CompletedNCT00488826
Wyeth is now a wholly owned subsidiary of PfizerPneumococcal Infections
Start: 2005-10-31End: 2007-05-31Updated: 2010-01-20

Phase 2

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea
CompletedNCT00689351
Wyeth is now a wholly owned subsidiary of PfizerPneumococcal Vaccine
Start: 2008-06-30End: 2009-12-31Updated: 2011-06-28

Phase 3

Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Children Receiving Solid Organ Transplants
CompletedNCT00213265
The Hospital for Sick ChildrenImmunosuppression, Organ Transplant
Start: 2002-07-31End: 2017-02-28Updated: 2021-02-15
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.
CompletedNCT00366340
Wyeth is now a wholly owned subsidiary of PfizerVaccines, Pneumococcal
Start: 2006-10-31End: 2008-08-31Updated: 2012-08-08
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants
CompletedNCT00366678
Wyeth is now a wholly owned subsidiary of PfizerVaccines, Pneumococcal
Start: 2006-10-31End: 2008-11-30Updated: 2012-08-15
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.
CompletedNCT00368966
Wyeth is now a wholly owned subsidiary of PfizerVaccines, Pneumococcal
Start: 2006-10-31End: 2008-07-31Updated: 2012-08-16
Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants
CompletedNCT00474539
Wyeth is now a wholly owned subsidiary of PfizerVaccines, Pneumococcal
Start: 2007-07-31End: 2009-03-31Updated: 2013-03-05
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants
CompletedNCT00475033
Wyeth is now a wholly owned subsidiary of PfizerVaccines, Pneumococcal Conjugate Vaccine
Start: 2007-06-30End: 2009-05-31Updated: 2011-04-21
A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China
CompletedNCT01692886
PfizerPneumococcal Infection
Start: 2012-08-31End: 2014-04-30Updated: 2014-07-16
Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)
CompletedNCT02736240
Walvax Biotechnology Co., Ltd.Diseases Caused by Streptococcus Pneumoniae Serotypes
Start: 2016-04-08End: 2017-12-03Updated: 2020-10-14

Phase 4

Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome
NCT01346007
National and Kapodistrian University of AthensIdiopathic Nephrotic Syndrome
Start: 2009-01-31End: 2011-06-30Target: 50Updated: 2011-05-02

Related Papers

Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China
BMJ Open2016-10-0111 citations